OVERVIEW
The horse presented with
- Moderate Grade 3 RF lameness, localized to the foot.
- Radiographic evidence of coffin joint osteoarthritis (OA).
- Prior surgical fusion of the distal interphalangeal joint (DIT) and tarsometatarsal (TMT) joints in the left hind (LH).
This combination of chronic structural changes, compensatory loading, and active inflammation created a multifactorial challenge requiring both mechanical and biologic consideration.
CLINICAL PRESENTATION
Initial evaluation
Lameness was consistent and load-dependent, indicating pain localized within the distal limb. Imaging confirmed coffin joint degeneration, a common but performance-limiting condition. Historical fusion in the LH suggested long-term biomechanical compensation, likely increasing strain on the RF limb. This is a classic example of how past orthopedic interventions can shift load distribution, ultimately contributing to new pathology.
Day 0 · Moderate Grade 3 RF, blocked to foot
TREATMENT APPROACH
The plan, in order
Given the complexity of the case, treatment focused on:
- Reducing inflammation within the joint.
- Supporting tissue at a cellular level.
- Improving overall limb function without adding further mechanical stress.
The decision was made to incorporate equine biologic therapy alongside standard care protocols.
OUTCOME
4 weeks: scored sound
Week 4 · Re-evaluation, scored sound
At re-evaluation:
- The horse was clinically sound.
- Significant improvement was observed in gait symmetry and load distribution.
- No adverse reactions were reported.
This rapid improvement suggests a strong response to treatment, particularly in a case where chronic degeneration and compensatory mechanics were both present.
WHY THIS CASE MATTERS
Several considerations in equine medicine
1. Compensation creates secondary injury
Previous surgical fusion altered biomechanics, increasing stress on the RF limb. Treating the “new” injury requires understanding the full orthopedic history.
2. OA is not just degenerative — it’s active
Coffin joint OA involves ongoing inflammation and cellular breakdown, not just wear and tear. Addressing inflammation alone may not be enough.
3. Biologic therapies fill the gap
In cases like this, biologics can:
- Support cellular repair signaling.
- Reduce inflammatory cascades.
CLINICAL TAKEAWAY
For horses presenting with
- Chronic lameness
- Joint degeneration
- History of orthopedic intervention
A multi-layered treatment approach is critical. This case demonstrates that even in complex, high-load scenarios, it is possible to:
- Restore soundness
- Improve performance potential
- Support long-term joint health
FINAL THOUGHT
Horse First. Sport Second.
At Equine Performance Labs, cases like this reinforce our core belief: meaningful recovery isn’t just about returning to work — it’s about restoring comfort, function, and longevity in every stride.
Considering equicenta® CTM for a specific patient?
Contact us today to discuss whether our proven biologic solution is right for your case. Every horse and every injury presents its own challenges. The goal is always to support the tissue environment in a way that prioritizes comfort, function, and long-term well-being.
Get More Info